ATE459640T1 - Sich an die protein phosphatase 2a bindende peptide und sie kodierende polynukleotide - Google Patents

Sich an die protein phosphatase 2a bindende peptide und sie kodierende polynukleotide

Info

Publication number
ATE459640T1
ATE459640T1 AT03780221T AT03780221T ATE459640T1 AT E459640 T1 ATE459640 T1 AT E459640T1 AT 03780221 T AT03780221 T AT 03780221T AT 03780221 T AT03780221 T AT 03780221T AT E459640 T1 ATE459640 T1 AT E459640T1
Authority
AT
Austria
Prior art keywords
protein phosphatase
ppa2
subunits
polynucleotides encoding
peptides binding
Prior art date
Application number
AT03780221T
Other languages
English (en)
Inventor
Alphonse Garcia
Xavier Cayla
Angelita Rebollo
Frederic Dessauge
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE459640T1 publication Critical patent/ATE459640T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT03780221T 2002-10-16 2003-10-13 Sich an die protein phosphatase 2a bindende peptide und sie kodierende polynukleotide ATE459640T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002408207A CA2408207A1 (fr) 2002-10-16 2002-10-16 Peptides liant la proteine phosphatase 2a et polynucleotides les codant
PCT/FR2003/003018 WO2004035611A2 (fr) 2002-10-16 2003-10-13 Peptides liant la proteine phosphatase 2a et polynucleotides les codant

Publications (1)

Publication Number Publication Date
ATE459640T1 true ATE459640T1 (de) 2010-03-15

Family

ID=32097367

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03780221T ATE459640T1 (de) 2002-10-16 2003-10-13 Sich an die protein phosphatase 2a bindende peptide und sie kodierende polynukleotide

Country Status (12)

Country Link
US (2) US7498306B2 (de)
EP (2) EP1565487B1 (de)
AT (1) ATE459640T1 (de)
AU (1) AU2003288320A1 (de)
CA (1) CA2408207A1 (de)
CY (1) CY1110650T1 (de)
DE (1) DE60331576D1 (de)
DK (1) DK1565487T3 (de)
ES (1) ES2342162T3 (de)
PT (1) PT1565487E (de)
SI (1) SI1565487T1 (de)
WO (1) WO2004035611A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2666481T3 (en) 2003-12-26 2019-02-25 Masatoshi Hagiwara A method for regulating the phosphorylation of SR protein and antiviral agents comprising an SR protein activity regulator as the active ingredient

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652211A (en) * 1991-02-11 1997-07-29 Biosynth S.R.L. Peptides for neutralizing the toxicity of Lipid A
US5700638A (en) * 1993-08-26 1997-12-23 Washington University Cell death regulator
US5789201A (en) * 1996-02-23 1998-08-04 Cocensys, Inc. Genes coding for bcl-y a bcl-2 homologue
US5821082A (en) * 1996-05-23 1998-10-13 St. Louis University Health Sciences Center Anti-proliferation domain of a human Bcl-2 and DNA encoding the same
ES2208942T3 (es) * 1996-07-05 2004-06-16 Philip E. Branton Proteinas e4 de adenovirus para inducir la muerte celular.
WO2001004629A1 (en) 1999-07-12 2001-01-18 Mcgill University E4orf4 and pp2a polypeptides, modulators, and mimetics for selectively inducing cell death
AU784561B2 (en) * 2000-06-23 2006-05-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Positively-charged peptide nucleic acid analogs with improved properties
US7521548B2 (en) * 2001-02-07 2009-04-21 Burnham Institute For Medical Research Apoptosis modulator Bcl-B and methods for making and using same
FR2827866B1 (fr) * 2001-07-27 2004-12-10 Pasteur Institut Peptides synthetiques ou naturels liant la proteine phosphatase 2a, methode d'identification et utilisations

Also Published As

Publication number Publication date
PT1565487E (pt) 2010-06-08
US7498306B2 (en) 2009-03-03
AU2003288320A1 (en) 2004-05-04
EP1565487A2 (de) 2005-08-24
DE60331576D1 (de) 2010-04-15
WO2004035611A3 (fr) 2005-06-30
HK1083850A1 (zh) 2006-07-14
WO2004035611A2 (fr) 2004-04-29
CA2408207A1 (fr) 2004-04-16
EP2243787A2 (de) 2010-10-27
CY1110650T1 (el) 2015-06-10
WO2004035611A8 (fr) 2004-07-08
US20100009909A1 (en) 2010-01-14
EP2243787A3 (de) 2011-05-18
EP1565487B1 (de) 2010-03-03
DK1565487T3 (da) 2010-06-21
ES2342162T3 (es) 2010-07-02
AU2003288320A8 (en) 2004-05-04
SI1565487T1 (sl) 2010-07-30
US20070065410A1 (en) 2007-03-22

Similar Documents

Publication Publication Date Title
MX2022011411A (es) Proteinas de union a antigeno que se unen especificamente a mage-a.
AR038568A1 (es) Anticuerpos anti-a beta y su uso
PE20251185A1 (es) Proteinas de union condicionalmente activadas restringidas
ATE482972T1 (de) Tgf-beta1-bindende und geträgerte peptide
EA200801621A1 (ru) Антитела, направленные на her-3, и их применение
RU2009128979A (ru) Hla*1101-ограниченный пептид wt1 и содержащая его фармацевтическая композиция
CA2395724A1 (en) Nucleic acids, proteins, and antibodies
AR047729A1 (es) Anticuerpos terapeuticos que se unen a la apolipoproteina e (apoe)
CY1109631T1 (el) Χρησιμοποιηση πεπτιδιων, τα οποια εχουν παραχθει απο την αα- ή ββ-αλυσιδα του ανθρωπινου ινωδογονου, για τη θεραπεια σοκ
BG101077A (bg) Пептиди
JP2019509037A5 (de)
EP2189471A4 (de) Foxm1-peptid und arzneimittel damit
EA201200515A1 (ru) Полипептиды и их применение
EP2030984A4 (de) Von sparc abgeleitetes krebsabstossungsantigenpeptid und pharmazeutikum, das dieses enthält
RU2008109015A (ru) Глипикан-3 (gpc3)-производные антигенные пептиды, отторгающие опухоли, используемые для нla-a2-положительных пациентов, и фармацевтическая продукция, включающая их
ATE440860T1 (de) An proteinphosphatase 2a bindende synthetische oder natürliche peptide, identifikationsverfahren und anwendungen
AR055179A1 (es) Procedimiento para la amidacion de polipeptidos con aminoacidos de caracter basico c-terminales mediante el uso de endoproteasas especificas
WO2020185796A9 (en) High avidity wt1 t cell receptors and uses thereof
AR042968A1 (es) Anticuerpos de virus anti-dengue composiciones metodos y usos
ATE308335T1 (de) Histidine-rich glycoprotein (hrgp) zur hemmung der angiogenese
JP2019038772A5 (de)
DE60331576D1 (de) Sich an die protein phosphatase 2a bindende peptide und sie kodierende polynukleotide
DK0667781T3 (da) Peptidbaserede diagnostiske og terapeutiske midler til spondylarthropatier
FI20050753A0 (fi) Uudet peptidit
EP1796707A4 (de) Peptide mit spezifischem sitz in herzgefässen und verwandte konjugate und verfahren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1565487

Country of ref document: EP